» Articles » PMID: 20110594

Cigarette Smoking is a Risk Factor for Alzheimer's Disease: an Analysis Controlling for Tobacco Industry Affiliation

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2010 Jan 30
PMID 20110594
Citations 138
Authors
Affiliations
Soon will be listed here.
Abstract

To examine the relationship between smoking and Alzheimer's disease (AD) after controlling for study design, quality, secular trend, and tobacco industry affiliation of the authors, electronic databases were searched; 43 individual studies met the inclusion criteria. For evidence of tobacco industry affiliation, http://legacy.library.ucsf.edu was searched. One fourth (11/43) of individual studies had tobacco-affiliated authors. Using random effects meta-analysis, 18 case control studies without tobacco industry affiliation yielded a non-significant pooled odds ratio of 0.91 (95% CI, 0.75-1.10), while 8 case control studies with tobacco industry affiliation yielded a significant pooled odds ratio of 0.86 (95% CI, 0.75-0.98) suggesting that smoking protects against AD. In contrast, 14 cohort studies without tobacco-industry affiliation yielded a significantly increased relative risk of AD of 1.45 (95% CI, 1.16-1.80) associated with smoking and the three cohort studies with tobacco industry affiliation yielded a non-significant pooled relative risk of 0.60 (95% CI 0.27-1.32). A multiple regression analysis showed that case-control studies tended to yield lower average risk estimates than cohort studies (by -0.27 +/- 0.15, P=0.075), lower risk estimates for studies done by authors affiliated with the tobacco industry (by -0.37 +/- 0.13, P=0.008), no effect of the quality of the journal in which the study was published (measured by impact factor, P=0.828), and increasing secular trend in risk estimates (0.031/year +/- 0.013, P=0.02). The average risk of AD for cohort studies without tobacco industry affiliation of average quality published in 2007 was estimated to be 1.72 +/- 0.19 (P< 0.0005). The available data indicate that smoking is a significant risk factor for AD.

Citing Articles

Relationship of tobacco smoking to cause-specific mortality: contemporary estimates from Australia.

Joshy G, Soga K, Thurber K, Egger S, Weber M, Sarich P BMC Med. 2025; 23(1):115.

PMID: 39994694 PMC: 11854379. DOI: 10.1186/s12916-025-03883-9.


Relationship of smoking cessation duration and cognitive function among middle-aged and older adults in China: a national cross-sectional study.

Zuo W, Peng J, Wu J Front Public Health. 2025; 12():1503152.

PMID: 39839407 PMC: 11747424. DOI: 10.3389/fpubh.2024.1503152.


ApoE Gene Polymorphism and Clinical, Biochemical, and Sociodemographic Characteristics of Alzheimer's Disease Patients From Northern and Southern Regions of Kazakhstan.

Zholdasbekova G, Kaiyrlykyzy A, Kassenova A, Alzhanova D, Klyuev D, Askarova S Int J Geriatr Psychiatry. 2024; 39(11):e70019.

PMID: 39568323 PMC: 11579630. DOI: 10.1002/gps.70019.


Tobacco cigarette smoking induces cerebrovascular dysfunction followed by oxidative neuronal injury with the onset of cognitive impairment.

Ewees M, El-Mahdy M, Hannawi Y, Zweier J J Cereb Blood Flow Metab. 2024; 45(1):48-65.

PMID: 39136181 PMC: 11572251. DOI: 10.1177/0271678X241270415.


Metformin ameliorates neuroinflammatory environment for neurons and astrocytes during in vitro and in vivo stroke and tobacco smoke chemical exposure: Role of Nrf2 activation.

Akter K, Sharma S, Sifat A, Zhang Y, Patel D, Cucullo L Redox Biol. 2024; 75:103266.

PMID: 39094400 PMC: 11345405. DOI: 10.1016/j.redox.2024.103266.


References
1.
Hillier V, Salib E . A case-control study of smoking and Alzheimer's disease. Int J Geriatr Psychiatry. 1997; 12(3):295-300. DOI: 10.1002/(sici)1099-1166(199703)12:3<295::aid-gps476>3.3.co;2-v. View

2.
Cho M, Bero L . The quality of drug studies published in symposium proceedings. Ann Intern Med. 1996; 124(5):485-9. DOI: 10.7326/0003-4819-124-5-199603010-00004. View

3.
Hebert L, Scherr P, Beckett L, Funkenstein H, Albert M, Chown M . Relation of smoking and alcohol consumption to incident Alzheimer's disease. Am J Epidemiol. 1992; 135(4):347-55. DOI: 10.1093/oxfordjournals.aje.a116296. View

4.
Lerner A, Koss E, Debanne S, Rowland D, Smyth K, Friedland R . Smoking and oestrogen-replacement therapy as protective factors for Alzheimer's disease. Lancet. 1997; 349(9049):403-4. DOI: 10.1016/S0140-6736(97)80025-6. View

5.
Siverstone F, BROD M, Levy A, Foley C, Termotto V, Breuer J . Are Alzheimer patients healthier?. J Am Geriatr Soc. 1988; 36(3):219-24. DOI: 10.1111/j.1532-5415.1988.tb01804.x. View